CRP uye Hs-CRP: Iyo Dual Dimensions yeInflammation Monitoring

C-reactive protein (CRP), seyakakosha biomarker yeacute kuzvimba uye hutachiona, musiyano wayo wakanyanya wehs-CRP (high-sensitivity C-reactive protein) yakawedzera kuwedzera miganhu yekiriniki yekushandisa. Iyo yakajairika CRP (ine yekuona huwandu hwe0.5 - 300 mg/L) inotarisa nekukurumidza. Kuongororwa yeacute infections, postoperative complications, uye sepsis, nepo Hs-CRP (ine chiyero chekutsvaga che 0.1 - 10 mg / L) inogona kunyatsotora zviratidzo zvekupisa zvakadzika, zvichipa hwaro hwakakosha hwehutachiona hwehutachiona hwehutachiona, kusingaperi kuzvimba kwekutonga, uye kuongororwa kwevanhu vasina hutano. Iko kusanganiswa kwekushandiswa kwehuviri-nucleus yekuona inowana kufukidzwa kwakazara kubva kune yakakosha kurapwa kwekukurumidzira kusvika pakudzivirira kwekutanga.

Evidence-based clinical application scenarios

1. Precise Diagnosis uye Stratification ye Infectious Zvirwere

Cooperative Detection yeCRP + PCT: Apo CRP ≥ 50 mg / L inosanganiswa nePCT ≥ 0.5 ng / mL, inoratidza hutachiona hwehutachiona (specific> 95%);

Kusiyanisa Viral Infections: Kana CRP ichikwidziridzwa zvishoma (10 - 40 mg / L) uye PCT yakajairika, hutachiona hwehutachiona kana hutachiona husina hutachiona hunofanira kuonekwa sechinhu chinonyanya kukosha.

2. Njodzi Ongororo yeCardiovascular Diseases

Kuongororwa kweChirwere Chisingaperi: CRP ≥ 3 mg / L inoratidza systemic yakaderera-giredhi kuputika, iyo inonyanya kubatanidzwa nenjodzi yeatherosclerosis;

Prognosis Kuongororwa kweCoronary Heart Disease: Muvarwere vane acute coronary syndrome, kana CRP ikaramba yakakwirira (> 10 mg / L), inoratidza kufungidzira kwakashata uye kunoda kusimbiswa kunopesana nekuputika.

3. Kutungamirirwa kweAutoimmune Diseases

Dynamic yekutevera yekuzvimba chiitiko: Iyo CRP level mune varwere vane Rheumatoid Arthritis inonyatsobatanidzwa nechirwere chechirwere (chinangwa chinokosha: CRP

Kuongororwa kwehutano hwekurapa: A ≥ 50% inoderera muCRP mushure mokunge biologic therapy inoratidza mhinduro yakanaka yekurapa.

4. Postoperative uye Intensive Care

Yambiro yehutachiona hwepashure: Kunonoka kuderera kwepamusoro peCRP level kana kuwedzera kunoramba kuripo (> 100 mg / L) mushure mekuvhiyiwa kunoratidza njodzi yezvinetso;

Kuzivikanwa kwepakutanga kwesepsis: CRP> 100 mg / L yakasanganiswa nePCT ≥ 2 ng / mL inogona kukurumidza kutanga kurapa kwehutachiona.

5. Risk Stratification uye Preventive Medicine yeCardiovascular Diseases

Kuongororwa kweasymptomatic vanhu: Hs-CRP ≥ 2 mg / L inoratidza kupetwa kaviri kwengozi yezviitiko zvemoyo. Yakasanganiswa neiyo lipid profile (yakadai seLDL-C), inogona kukwidziridza iyo njodzi yekufanotaura modhi (sezvinokurudzirwa neACC/AHA nhungamiro);

Kuongororwa kwekuita kwekupindira: Mushure mekurapa kwe statin, Hs-CRP yakaderedzwa kusvika

Kune vanhu kuongororwa kwechirwere chekuzvimba uye CVD yekuongorora cutoffs yakakurudzirwa. Sezvizvi:

6. Kutarisira Zvirwere Zvisingaperi Metabolic

Chirwere cheDiabetes Complication Warning: Kuramba kukwidziridzwa kweHs-CRP (> 3 mg / L) kune varwere vane chirwere cheshuga chechipiri chinoratidza dambudziko re microvascular uye cardiovascular renal complications, inoda kusimbiswa kwakazara kutungamirirwa;

Kutariswa kweKufutisa-Kune Hutano Hwakasvibiswa: Nhamba yeHs-CRP yakanyatsobatanidzwa ne visceral mafuta accumulation, ichipa huwandu hwehuwandu hwekupindira kwehupenyu.

7. Precision Diagnosis uye Kurapwa kweAutoimmune Zvirwere

Kuzivikanwa kwe subclinical inflammation: Kuonekwa kweHs-CRP kunogona kubatsira kuziva zvipembenene zvekunze (zvakadai sekubatanidzwa kwemwoyo) kune varwere vane rheumatoid arthritis panguva yekutanga, kutungamirira mishonga yakawanda yakabatanidzwa;

Kugadziriswa kwesimba kwezvinangwa zvekurapa: Pasi pekurapwa kwakasanganiswa nebiologics, iyo Hs-CRP nhanho isingasviki 1 mg/L inogona kushandiswa sechikumbaridzo chereferensi yekupedza kuzvimba.

Lamuno (Fluorescence immunoassay chikuva): CRP/Hs-CRP mbiri mbiri, kuseta chiyero chitsva cheindasitiri

Kuonekwa kweDual-core ne flexible switching: Iyo imwe puratifomu inotsigira ese akajairwa CRP (acute phase) uye Hs-CRP (chronic phase) bvunzo. Nekungochinja makadhi reagent, mhedzisiro inogona kubuda panguva imwe chete mukati memaminitsi gumi nemashanu, ichisangana nezvinodiwa zvekiriniki zvakasiyana.
Super precision performance chivimbiso: Kunzwa kweHs-CRP kunosvika 0.5 mg / L, kunyatsoziva zviratidzo zvekupisa kwepasi-concentration;

Linear range: CRP 0.5-200 mg / L, seamless kubatanidza emergency uye chirwere chisingaperi mamiriro ekugadzirisa zvirwere.

Compact dhizaini: Inokodzera akasiyana ekushandisa mamiriro.

Kubva Kurapa Emergency kusvika Kudziviriro: Redefining Inflammation Management

Lamuno inobatanidza kuviriswa kweCRP neHs-CRP, kutyora zvipingamupinyi zvekutarisa kuzvimba kwechinyakare. Muzviitiko zvekukurumidzira, inokurumidza kuziva kunobva hutachiona uye inotungamira kushandiswa kwemishonga inorwisa mabhakitiriya; mumunda wezvirwere zvisingaperi, inofanotaura zviitiko zvemwoyo 10 makore zvisati zvaitika, zvichikurudzira kushandiswa kwe "kudzivirira zvirwere zvisati zvaitika". Ichi chitsva hachingonatsiridza kugona kwekugovera zviwanikwa muhutano asi zvakare chinogonesa varwere hutano hwehupenyu hwese kuburikidza neiyo data chaiyo, ichipa tsigiro yetekinoroji yekudzivirira hutano nekudzora hurongwa.